Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-21-012063
Filing Date
2021-03-10
Accepted
2021-03-10 16:16:10
Documents
82
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K FY20 harp-10k_20201231.htm 10-K 3920737
2 EX-23.1 harp-ex231_10.htm EX-23.1 7062
3 EX-31.1 harp-ex311_8.htm EX-31.1 22293
4 EX-31.2 harp-ex312_14.htm EX-31.2 22641
5 EX-32.1 harp-ex321_9.htm EX-32.1 12914
6 GRAPHIC ggk3duykvh1o000003.jpg GRAPHIC 93930
7 GRAPHIC ggk3duykvh1o000001.jpg GRAPHIC 177050
8 GRAPHIC ggk3duykvh1o000002.jpg GRAPHIC 163637
  Complete submission text file 0001564590-21-012063.txt   13981191

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT harp-20201231.xml EX-101.INS 3346897
10 XBRL TAXONOMY EXTENSION SCHEMA harp-20201231.xsd EX-101.SCH 67035
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE harp-20201231_cal.xml EX-101.CAL 56588
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE harp-20201231_def.xml EX-101.DEF 279316
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE harp-20201231_lab.xml EX-101.LAB 528283
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE harp-20201231_pre.xml EX-101.PRE 425400
Mailing Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

EIN.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38800 | Film No.: 21729884
SIC: 2836 Biological Products, (No Diagnostic Substances)